WO2022175435 - AMYLASE VARIANTS
National phase entry:
Publication Number
WO/2022/175435
Publication Date
25.08.2022
International Application No.
PCT/EP2022/054045
International Filing Date
18.02.2022
Title **
[English]
AMYLASE VARIANTS
[French]
VARIANTS D'AMYLASE
Applicants **
BASF SE
Carl-Bosch-Strasse 38
67056 Ludwigshafen Am Rhein, DE
HENKEL AG & CO. KGAA
Henkelstrasse 67
40589 Düsseldorf, DE
Inventors
NIELSEN, Jesper
3550 John Hopkins Court
San Diego, CA 92121, US
POP, Cristina
3550 John Hopkins Court
San Diego, CA 92121, US
JENEWEIN, Stefan
Carl-Bosch-Strasse 38
67056 Ludwigshafen, DE
LYON, Jonathan
3550 John Hopkins Court
San Diego, CA 92121, US
MILLER, Mark
3550 John Hopkins Court
San Diego, CA 92121, US
LOGUE, Amanda Rae
3550 John Hopkins Court
San Diego, CA 92121, US
KLINE, Katie
3550 John Hopkins Court
San Diego, CA 92121, US
HOANG, Cindy
3550 John Hopkins Court
San Diego, CA 92121, US
WIELAND, Susanne
Schlossstrasse 25
41541 Dormagen-Zons, DE
DEGERING, Christian
Hauptstrasse 53
40699 Erkrath, DE
Priority Data
21158484.2
22.02.2021
EP
21213738.4
10.12.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 3000 | |
| EPO | Filing, Examination | 11001 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 8710 |
Total: 23909 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
In the present invention new amylase enzymes are provided. More specifically, genetically engineered amylase enzymes, compositions comprising the enzymes, and methods of making and using the enzymes or compositions comprising the enzymes are provided.[French]
La présente invention concerne de nouvelles enzymes amylase. Plus spécifiquement, l'invention concerne des enzymes amylase génétiquement modifiées, des compositions comprenant les enzymes, et des procédés de fabrication et d'utilisation des enzymes ou des compositions comprenant les enzymes.